Filtered By:
Condition: Atrial Fibrillation
Procedure: Angioplasty
This page shows you your search results in order of date.
Order by Relevance | Date
Total 397 results found since Jan 2013.
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX ™ Pro Left Atrial Appendage Closure Device
Designed to further advance the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers and a broader size matrix to treat a wider range of patients.
Source: News from Angioplasty.Org - September 8, 2023 Category: Cardiology Source Type: news
O06/60 Diagnosis of intracranial atherosclerosis related large vessel occlusion before endovascular treatment
ConclusionA combination of clinical and radiological variables available before EVT can accurately predict the presence of an ICAD-LVO. The ICAD-Scale could be useful to perform a rapid assessment of underlying etiology and suggest specific pathophysiology-based measures (adjunctive pharmacological treatment, angioplasty and/or intracranial stenting).Disclosure of InterestDr Molina reported receiving personal fees from AstraZeneca for consultant services outside the submitted work. Dr Tomasello reported receiving personal fees from Anaconda Biomed, Balt, Medtronic, Perflow, and Stryker outside the submitted work. Dr Ribo r...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Rodrigo-Gisbert, M., Garcia-Tornel, A., Requena, M., Rubiera, M., Lascuevas, M. D. D., Olive, M., Pinana, C., Rizzo, F., Muchada, M., Rodriguez-Villatoro, N., Rodriguez-Luna, D., Juega, J., Pagola, J., Hernandez, D., Molina, C. A., Tomasello, A., Ribo, M. Tags: 2.2 ISCHEMIC - Imaging Source Type: research
Direct Oral Anticoagulants in the Setting of Percutaneous Coronary Intervention: “There Will Be Blood”
Direct oral anticoagulants (DOACs) are being increasingly used in clinical practice for various indications ranging from treatment of venous thromboembolism1 to stroke thromboprophylaxis in atrial fibrillation.2 Clinical practice guidelines now endorse DOACs in preference to vitamin K antagonists (VKAs) for thromboprophylaxis in patients with atrial fibrillation and after venous thromboembolism, reflecting the favorable efficacy and safety profile of this anticoagulant class compared with VKA.3 Despite increasing DOAC utilization, the optimal periprocedural antithrombotic management for patients treated with DOAC who under...
Source: The American Journal of Cardiology - August 12, 2023 Category: Cardiology Authors: Maximillian T. Bourdillon, Konstantinos Charitakis Tags: Editorial Source Type: research
The Prognostic Implications of Living Alone on Long-Term Mortality in Patients with Chronic Coronary Syndrome after Percutaneous Coronary Intervention
Int Heart J. 2023;64(4):584-589. doi: 10.1536/ihj.23-063.ABSTRACTLiving alone is associated with increased cardiac events and mortality in patients with acute myocardial infarction. However, the prognostic impact of living alone with chronic coronary syndrome (CCS) still remains unclear. In the present study, we examined the relationship between living alone and long-term mortality in patients with CCS who underwent percutaneous coronary intervention (PCI).Consecutive 830 patients with CCS who underwent PCI were enrolled and divided into 2 groups according to whether or not they were living alone at the time of admission (...
Source: International Heart Journal - July 30, 2023 Category: Cardiology Authors: Daisuke Isomatsu Akihiko Sato Yuya Sakuma Yuta Kurosawa Yuki Muto Yu Sato Takatoyo Kiko Takeshi Shimizu Tomofumi Misaka Akiomi Yoshihisa Takayoshi Yamaki Kazuhiko Nakazato Takafumi Ishida Yasuchika Takeishi Source Type: research
